Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pharvaris N.V.PHVS · Entity 4374 | Chief Early Development | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pharvaris N.V.
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GrayMatters Consulting BVBA | 73,969 |
Reported balance
After 2026-09-17 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-17 · Sale · Disposed 20,000 · Balance 73,969 F1: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.04 to $38.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F2: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage |
| Common StockSEC Table I · non-derivative | Direct | 56,450 |
Reported balance
Holding disclosure · report date 2026-09-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 56,450 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.04 to $38.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 21, 2026 19:13 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 20,000 | $38.27 | $765,466.00 |
DisclosureSEC source: 0001193125-26-396572 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: No plan indicated Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 73,969 F1 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.04 to $38.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 16:29 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-390119 · ownership.xml · derivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 8,000 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 16:29 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 30,000 | $38.30 | $1,149,084.00 |
DisclosureSEC source: 0001193125-26-390119 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.00 to $38.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 16:29 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 30,000 | $8.05 | $241,500.00 |
DisclosureSEC source: 0001193125-26-390119 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,972 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 16 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,972 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F10 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 13 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 24,900 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F9 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 30,703 | $35.49 | $1,089,637.19 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 11 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 93,969 F5 · kind: This is a scheduled sale from 10b5-1 trading plan. F8 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 27,872 | $35.48 | $988,890.20 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 9 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.84. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 24,900 | $8.05 | $200,445.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 8 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 2,972 | $2.59 | $7,697.48 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 7 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,100 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 15 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,972 Underlying: Common Stock · 4,100 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F10 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,400 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 14 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,072 Underlying: Common Stock · 1,400 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F10 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,200 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 12 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,900 Underlying: Common Stock · 4,200 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F9 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 6,997 | $35.05 | $245,231.56 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 10 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 124,672 F5 · kind: This is a scheduled sale from 10b5-1 trading plan. F6 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 8,300 | $35.05 | $290,907.53 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 6 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to 35.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 2,300 | $35.12 | $80,785.66 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 5 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 4,200 | $8.05 | $33,810.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 4 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 4,100 | $2.59 | $10,619.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 900 | $8.05 | $7,245.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 1,400 | $2.59 | $3,626.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,400 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · derivative · entry 6 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,072 Underlying: Common Stock · 1,400 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F5 · derivative.exercise_date: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 900 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · derivative · entry 5 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,100 Underlying: Common Stock · 900 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 2,300 | $35.12 | $80,785.66 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 4 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 131,669 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 2,300 | $35.12 | $80,774.62 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 900 | $8.05 | $7,245.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 1,400 | $2.59 | $3,626.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · derivative · entry 11 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,000 Underlying: Common Stock · 18,000 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F7 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,700 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · derivative · entry 10 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,072 Underlying: Common Stock · 3,700 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F6 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 19,200 | $30.26 | $580,909.44 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 8 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BV Disclosed balance after: 133,969 F3 · kind: This is a scheduled sale from 10b5-1 trading plan. F5 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 18,000 | $30.26 | $544,604.40 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 6 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 18,000 | $8.05 | $144,900.00 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 5 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 3,700 | $30.26 | $111,946.46 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 4 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 30, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 3,700 | $2.59 | $9,583.00 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 29, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,700 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · derivative · entry 9 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,772 Underlying: Common Stock · 3,700 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F6 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| April 29, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 3,700 | $30.06 | $111,229.40 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 7 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BV Disclosed balance after: 153,169 F3 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| April 29, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 3,700 | $30.08 | $111,280.46 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 29, 2026 Filed May 1, 2026 23:30 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 3,700 | $2.59 | $9,583.00 |
DisclosureSEC source: 0001193125-26-201925 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · derivative · entry 11 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,872 Underlying: Common Stock · 100 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · derivative.exercise_date: 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 100 | $30.03 | $3,003.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 8 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F3 · price: These shares were sold in multiple transactions at prices ranging from $30.03 to $31.03. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 100 | $2.59 | $259.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 7 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 100 | $30.03 | $3,003.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 6 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · GrayMatters Consulting B.V. Disclosed balance after: 156,869 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · derivative · entry 10 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,000 Underlying: Common Stock · 7,000 shares Expires 2031-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F5 · derivative.exercise_date: 25% of the option vested on February 5, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · derivative · entry 9 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,972 Underlying: Common Stock · 500 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · derivative.exercise_date: 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 7,000 | $30.05 | $210,357.70 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 5 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · GrayMatters Consulting B.V. Disclosed balance after: 156,969 F2 · price: These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 7,000 | $30.05 | $210,361.90 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 4 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 7,000 | $8.05 | $56,350.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 500 | $30.00 | $15,000.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 16:18 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 500 | $2.59 | $1,295.00 |
DisclosureSEC source: 0001193125-26-176222 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.